TRAP1 — MOA And Pipeline Page (Page 1124)
Bulk / Single Cell Transcriptomics Plan (continuation)
| Sonia Gandhi (UCL), Steven Lee (University of Cambridge), Michele Vendruscolo (University of Cambridge) | and human brain tissues | relevant regions and over different cell types, → 이 map에서 oligomer-containing cell을 골라→ LCM (laser capture microdissection)으로 single cell 빼내 → sc trnscriptomics. genomics (ie SNP발굴, 이것도 oligomer-containing인지 불언급) -validation: iPSC+oligomer→ readouts: ROS, mito, Ca, synapse, UPR, oligomer flux | |
|---|---|---|---|
| Mice | (Zhong, 2020 #1309) 6-month old α-syn A53T | region-specific dysfunctions regarding proteostasis, channelosome (calcium지칭듯), extracellular environment, neuroinflammation → BM제안 (high fidelity BM) |
Midbrain DA neurons
| Midbrain DA neurons | DA neurons in other brain regions | |
|---|---|---|
| Developmental path | develop from radial 21 glial cells of the foor plate | Develop from neural stem cells |
| During development | exposed to high levels of the SHH transcription factor | Determined by Pax6 transcription factor |
| transcriptome | Different transcriptome |
TRAP1
| gene | protein | function | Pipeline |
|---|---|---|---|
|
TRAP1 (TNF Receptor Associated Protein 1) Maiko: Peter Maycox is working in TRAP1. |
Heat shock protein 75 kDa, =mitochondrial member of Hsp90 family, resides in mito matrix, phosphorylated by PINK1, TRAP1 protein comprises an N-terminal ATPase domain, a middle domain and a C-terminal dimerization domain. |
https://www.uniprot.org/uniprot/Q12931
Mt ETC mbe. potential, ETC Seahorse (OCR), Mito Stress Test kit | Amathus: TRAP1 positive allosteric modulator (PAM) |
| sharefoleder | https://onetakeda.box.com/s/atojegv302eix7lt6ln1lk97gwfddyva | ||
MOA
| normal | PINK1 phosphorylates TRAP1 | ↑TRAP1 phosphorylation | Client proteins | (ATP → ↑ADP). | mt depolarization | |||
|---|---|---|---|---|---|---|---|---|
| ↑N-terminal ATPase domain, | ||||||||
| TRAP1 Inhibit cytochrome c oxidase | ||||||||
| TRAP1 binds and Inhibit succinate dehydrogenase (SDH, =mc2) | 그럼 이론상으론, ↑succinate (근데 PD plasma에선 ↓), ↓fumarate | ↓MC2 activity, ↓OCR (Sciacovelli, 2013 #2405) | ↓ATP synthesis (Sciacovelli, 2013 #2405) | |||||
| TRAP1 interacts w F-ATP synthase | ↑F-ATP synthase activity | |||||||
| ?↓TRAP1 phosphorylation | ↓TRAP1 function (KD) | mt fragmentation | ||||||
| PD | ? | |||||||
| Tx Hypothesis | PD+ ↑TRAP1 (ie PAM) | ↑ATPase activity (eg.Amathus compound 20231019 | Client protein synergy | OCR: Seahorse | ↓(감소시키려한다 게 맞을 듯) Mito ETC: | ↓ROS | ||
| ↓aSyn ? |
in vitro pharmacology
| meeting slide #28) | ||||||||
|---|---|---|---|---|---|---|---|---|
| in vitro pharmacology | Target | ↑(50%) ATPase activity - 100 nM in i)human ATPase ADP-Glo & ii)Rodent (rat & mouse) | ↑ expression of at least two from; SDHB, SIRT3, NDUFS1 (additional client proteins - CDK4, PRDX3) | EC50<1uM | EC50<1uM | |||
| Progress 20230914 | Methods developed for three proteins (Jess) SHDB, SIRT3 and NDUFS1 | CellROX staining (이게 아마 started developing) | ||||||
| progress 20231005 | Client protein assay ready for compound screening. | ROS assay is almost ready to be completely developed. | ||||||
| Progress 20231018 | 3 ADP-Glo assays (hTRAP1, Rodent TRAP1, HSP90) successfully developed and used in hit finding activities → being used for routine screening | Assay developed 3 principal client proteins (SDHB, Sirt3, NDUFS1). → being used for routine screening | CDA in place → (next step) MSA | Provisional conditions established; initial test compounds provided including Amathus patent compounds. → next step: Optimisation of compound treatment times. | ||||
| Progress 20231130 | Complete repeat of 2nd Jess client protein run • Results consistent with other compounds — N=1 dataset indicates increases in NDUFS1 observed but no clear Sirt3/SDHB | No activity observed in ROS assay for Amathus patent compounds when tested following longer compound preincubation. • Further optimisation appears to have had a positive impact on variability. |
Uncertain Spans
| location | transcription | uncertainty |
|---|---|---|
| TRAP1 transcriptomics row | 이것도 oligomer-containing인지 불언급 | The penultimate Hangul token is rendered ambiguously between 불언급 and 불인급 in the OCR; the preferred reading 불언급 (“not mentioned”) matches the surrounding clause. |
| Mice row | channelosome (calcium지칭듯) | The hand-typed Korean note reads as 지칭듯 (“seems to refer to”) but the small font near the column edge keeps the second syllable visually close to 징. |
| MOA grid, leftmost rows | row labels | The leftmost two columns of the MOA grid are largely blank in this capture; some state-row labels (between “Client proteins” header and “Tx Hypothesis”) remain unlabeled rather than cut off. |
| in vitro pharmacology grid, right edge | progress columns past EC50<1uM | The rightmost progress narrative cells extend off the photo edge near the binding column and continue in 20240722_184539; only the cells fully visible in this capture are transcribed here. |